Oliver Deuster

1.0k total citations
19 papers, 790 citations indexed

About

Oliver Deuster is a scholar working on Pathology and Forensic Medicine, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Oliver Deuster has authored 19 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Cellular and Molecular Neuroscience and 5 papers in Immunology. Recurrent topics in Oliver Deuster's work include Macrophage Migration Inhibitory Factor (5 papers), Nuclear Receptors and Signaling (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Oliver Deuster is often cited by papers focused on Macrophage Migration Inhibitory Factor (5 papers), Nuclear Receptors and Signaling (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Oliver Deuster collaborates with scholars based in Germany, United States and Switzerland. Oliver Deuster's co-authors include Michael Bacher, Richard Dodel, Carmen Noelker, Monika Balzer‐Geldsetzer, Johannes Sander, Daniel C. Brune, Andrea Schulte, Christiane Dahl, Frauke Neff and Yousef Al‐Abed and has published in prestigious journals such as Journal of Neuroscience, Blood and Cancer.

In The Last Decade

Oliver Deuster

17 papers receiving 773 citations

Peers

Oliver Deuster
Yanhong Huang China
Cheng Han China
W. Marcus Lambert United States
Hang Xu China
Ya Wang China
Pouria Heydarpour Iran
Laura Scott South Africa
Yajing Zhu China
Die Hu China
Yanhong Huang China
Oliver Deuster
Citations per year, relative to Oliver Deuster Oliver Deuster (= 1×) peers Yanhong Huang

Countries citing papers authored by Oliver Deuster

Since Specialization
Citations

This map shows the geographic impact of Oliver Deuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Deuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Deuster more than expected).

Fields of papers citing papers by Oliver Deuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Deuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Deuster. The network helps show where Oliver Deuster may publish in the future.

Co-authorship network of co-authors of Oliver Deuster

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Deuster. A scholar is included among the top collaborators of Oliver Deuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Deuster. Oliver Deuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Möhr, Michael, Matthias Büttner, Oliver Deuster, et al.. (2024). E-Health-based, trans-sectoral, geriatric health service – Geriatric Network (GerNe). Scientific Reports. 14(1). 17326–17326.
2.
Singer, Susanne, et al.. (2024). „Patient-reported outcomes“ in medizinischen Registern. PUBLISSO (German National Library of Medicine). 30(4). 304–311.
3.
Rapp, Kilian, Gisela Büchele, Michel Wensing, et al.. (2024). Multimodal home-based rehabilitation intervention after discharge from inpatient geriatric rehabilitation (GeRas): study protocol for a multicenter randomized controlled trial. BMC Geriatrics. 24(1). 69–69. 4 indexed citations
4.
5.
Legenbauer, Tanja, Michael Kölch, Olaf Reis, et al.. (2024). Bright Light Therapy as Add-On to Inpatient Treatment in Youth With Moderate to Severe Depression. JAMA Psychiatry. 81(7). 655–655. 5 indexed citations
6.
Heß, Georg, Andreas Hüttmann, Mathias Witzens‐Harig, et al.. (2022). A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial. British Journal of Haematology. 198(3). 482–491. 4 indexed citations
7.
8.
Wölfling, Klaus, Kai W. Müller, Michael Dreier, et al.. (2019). Efficacy of Short-term Treatment of Internet and Computer Game Addiction. JAMA Psychiatry. 76(10). 1018–1018. 121 indexed citations
9.
Heß, Georg, Andreas Hüttmann, Julia Meißner, et al.. (2018). Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma:Â a Phase II Trial (GOAL). Blood. 132(Supplement 1). 1678–1678. 1 indexed citations
10.
Ferner, Marion, Daniel Wachtlin, Torsten Konrad, et al.. (2015). Rationale and design of the RE-LATED AF—AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus—Effects of Dabigatran in patients with Atrial Fibrillation. Clinical Research in Cardiology. 105(1). 29–36. 33 indexed citations
11.
Mengel, David, Frauke Neff, Kalpana Balakrishnan, et al.. (2013). Naturally occurring autoantibodies interfere with β-amyloid metabolism and improve cognition in a transgenic mouse model of Alzheimer’s disease 24 h after single treatment. Translational Psychiatry. 3(3). e236–e236. 26 indexed citations
12.
Dodel, Richard, B. Karthikeyan, Kathy Keyvani, et al.. (2011). Naturally occurring autoantibodies against beta-amyloid: investigating their role in transgenic animal and in vitro models of Alzheimer's disease. PMC. 42 indexed citations
13.
Deuster, Oliver, Carmen Noelker, Carsten Stüer, et al.. (2011). Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. Journal of Neuroscience Research. 89(5). 711–717. 33 indexed citations
14.
Dodel, Richard, B. Karthikeyan, Kathy Keyvani, et al.. (2011). Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal andIn VitroModels of Alzheimer's Disease. Journal of Neuroscience. 31(15). 5847–5854. 103 indexed citations
15.
Bacher, Michael, Oliver Deuster, Bayan Aljabari, et al.. (2010). The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease. Molecular Medicine. 16(3-4). 116–121. 73 indexed citations
16.
Schrader, Jörg, Oliver Deuster, Martina Schulz, et al.. (2009). Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown. BMC Cancer. 9(1). 464–464. 19 indexed citations
17.
Bach, Jan‐Philipp, Oliver Deuster, Monika Balzer‐Geldsetzer, et al.. (2009). The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer. 115(10). 2031–2040. 69 indexed citations
18.
Popp, Julius, Michael Bacher, Heike Kölsch, et al.. (2008). Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease. Journal of Psychiatric Research. 43(8). 749–753. 70 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanhong Huang Breakdown of academic impact, for papers by Cheng Han Breakdown of academic impact, for papers by W. Marcus Lambert Breakdown of academic impact, for papers by Hang Xu Breakdown of academic impact, for papers by Ya Wang Breakdown of academic impact, for papers by Pouria Heydarpour Breakdown of academic impact, for papers by Laura Scott Breakdown of academic impact, for papers by Yajing Zhu Breakdown of academic impact, for papers by Die Hu
Rankless by CCL
2026